Sage Journals: Discover world-class research

Open access

Case report

First published 2020

Acquired multiple mutations ALK I1171N,L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report

Jia Hu, Baoshi Zhang, Fangfang Yao [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2019-12

Relationship of radiometabolic biomarkers to KRAS mutation status and ALK rearrangements in cases of lung adenocarcinoma

Gulfidan Aras, Zehra Dilek Kanmaz, Esin Tuncay [...]

Tumori Journal

Open access

Case report

First published 2015

Lung adenocarcinoma with Concurrent KRAS Mutation and ALK Rearrangement Responding to Crizotinib: Case Report

Saul Campos-Gomez, Humberto Lara-Guerra, Mark J. Routbort [...]

The International Journal of Biological Markers

Retricted access

Research article

First published 2017

Relationship of Radiometabolic Biomarkers to KRAS Mutation Status and ALK Rearrangements in Cases of Lung Adenocarcinoma

Gulfidan Aras, Zehra Dilek Kanmaz, Esin Tuncay [...]

Tumori Journal

Retricted access

Case report

First published 2018-4

Concomitant Presence of EGFR and ALK Fusion Gene Mutation in Adenocarcinoma of Lung: A Case Report and Review of the Literature

Nishitha Thumallapally, Hana Yu, Mohammad Farhan [...]

Journal of Pharmacy Practice

Retricted access

Other

First published 2006-8

A Novel Mutation in ALK-1 Causes Hereditary Hemorrhagic Telangiectasia Type 2

Z.M. Yan, Z.P. Fan, J. Du [...]

Journal of Dental Research

Retricted access

Case report

First published 2024-12

Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs

Rita Leporati, Daniela Miliziano, Teresa Beninato [...]

Tumori Journal

Retricted access

Review article

First published 2022-2

Two different patterns of lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement

Dashi Zhao, Jun Fan, Li Peng [...]

Tumori Journal

Open access

Case report

First published 2025-10

Durable response with mutation-guided ALK inhibition in a patient with metastatic epithelioid inflammatory myofibroblastic sarcoma: A case report

Sumra S. Chaudhry, D. Ross Camidge, Michael R. Clay [...]

Rare Tumors

Retricted access

Review article

First published 2012-6

Targeted therapy for NSCLC: ALK inhibition

Rachel Pearson, Jill M Kolesar

Journal of Oncology Pharmacy Practice

Search results